Abstract
1-Cyclopropylcyclopropanecarboxylic acid (2), which is accessible on a large scale (900 mmol) from 1-bromo-1-cyclopropylcyclopropane (1) in 64% yield (89% on a 12.4 mmol scale), has been subjected to a Curtius degradation employing the Weinstock protocol to furnish the N-Boc-protected (1-cyclopropyl)cyclopropylamine 3 (76%). Deprotection of 3 with hydrogen chloride in diethyl ether gave the (1-cyclopropyl)cyclopropylamine hydrochloride (4·HCl) in 87% yield.
Keywords: amines, building blocks, carboxylic acids, Curtius degradation, cyclopropanes
Introduction
Several recent patent applications have stirred an increasing interest in research departments of pharmaceutical and agrochemical companies concerning 1- and 2-substituted 1,1'-bicyclopropyl derivatives. Among them, intermediates containing a (1-cyclopropyl)cyclopropylamine moiety appear to be particularly important and desirable for the preparation of biologically active and pharmacologically relevant compounds. For example, a number of derivatives of (1-cyclopropyl)cyclopropylamine (4) have been found to be useful variously for the treatment of hepatitis C [3–4], as pest control agents [5], as inhibitors of methicillin-resistant Staphylococcus aureus [5], as pesticides, insecticides and acaricides [7–13] and more. This amine has been prepared from cyclopropyl cyanide [3–13] by application of the Szymoniak–Kulinkovich reductive cyclopropanation procedure [14–15]. In our hands, however, this patented protocol [3–13] provided poor yields (15–20%) of impure 4 [16], which had to be purified by conversion to the corresponding tert-butyl carbamate and subsequent column chromatography. Thus, this procedure was not easily scalable to 10–50 g quantities. To meet such demands, we have developed an alternative route to 4 from the easily available corresponding carboxylic acid 2 [17–18] by Curtius degradation [19–20].
Results and Discussion
Preparation of the acid 2 from the known 1-bromo-1-cyclopropylcyclopropane (1) [21–22] according to the published procedure [17] was accomplished on a 100 g scale (Scheme 1). However, the yield of the carboxylation on a scale of 12.4 mmol, 900 mmol and 1400 mmol, was 89, 64 and 62%, respectively. This is associated with the longer reaction time employed on a larger scale, during which the intermediate 1-cyclopropyl-1-lithiocyclopropane may be trapped by the by-product tert-butyl bromide, leading to isobutene by dehydrobromination [23–24]. Indeed, the reaction on a 200 mmol scale, but over a period of 3 h, furnished 2 in 46% yield only. According to previous experience, this undesired side reaction can be suppressed by employing two equivalents of tert-butyllithium [23]. Thus, the yield of 2 may be improved even for large scale preparation.
Scheme 1.
Preparation of 1-(cyclopropyl)cyclopropylamine hydrochloride (4·HCl).
Curtius degradation of the acid 2 via the corresponding azide, according to the Weinstock protocol [19–20] as previously employed in different examples [2,25], furnished the N-Boc-protected (1-cyclopropyl)cyclopropylamine 3 in 76% yield. It was essential to carefully dry the solution of the intermediate azide, otherwise the yield of 3 dropped dramatically, and the desired product was accompanied by 1,3-di(bicyclopropyl)urea (5) in up to 50% yield (Scheme 1). The structure of the latter was confirmed by an X-ray crystal structure analysis (Figure 1) [26].
Figure 1.
Structure of 1,3-di(bicyclopropyl)urea (5) in the crystal [26].
The carbamate 3 was deprotected by treatment with hydrogen chloride in diethyl ether affording the amine hydrochloride 4·HCl in 87% yield. The latter was thus obtained from 1-bromo-1-cyclopropylcyclopropane (1) on a scale of 50 g in 42% overall yield (Scheme 1).
Conclusion
The newly developed procedure allows the preparation of 1-(cyclopropyl)cyclopropylamine (4) in five steps from commercially available methyl cyclopropanecarboxylate, reproducibly, on a 50 g and even larger scale. In this respect it is superior to the previously published and patented access to 4 from cyclopropanecarbonitrile, which in the hands of five different researchers in our laboratory required chromatographic separation of the intermediately prepared N-Boc derivative, which involved the rather costly di-tert-butyl pyrocarbonate and made that an overall three-step procedure.
Experimental
1H and 13C NMR spectra were recorded at 300 MHz [1H] and 62.9 MHz [13C, additional DEPT (Distortionless Enhancement by Polarization Transfer)] on Bruker AM 250 and Varian Mercury Vx300 instruments in CDCl3 and D2O solutions, CHCl3/CDCl3 and DHO as internal references. EI-MS, ESI-MS and HRMS spectra were measured with Finnigan MAT 95 (70 eV), Finnigan LCQ and Bruker Daltonic APEX IV 7T FTICR instruments, respectively. Melting points were determined on a Büchi 510 capillary melting point apparatus, values are uncorrected. TLC analyses were performed on precoated sheets (0.25 mm Sil G/UV254) from Macherey-Nagel). All chemicals were used as received. 1-Bromo-1-cyclopropylcyclopropane (1) was obtained according to the previously published procedure [21]. A 5.0 N solution of HCl in Et2O was prepared by saturation of anhydrous Et2O with gaseous HCl at 0 °C. Anhydrous diethyl ether was obtained by distillation from sodium benzophenone ketyl, acetone by distillation from anhydrous potassium carbonate. Anhydrous tert-butyl alcohol was obtained employing molecular sieves (4 Å) [27]. Organic extracts were dried over MgSO4. All reactions in anhydrous solvents were carried out under an argon atmosphere in flame-dried glassware.
Synthesis of 1-cyclopropylcyclopropanecarboxylic acid (2)
Under mechanical stirring and cooling with pentane/liq. N2, a solution of t-BuLi (1.7 M in pentane, 560 mL, 952.0 mmol) was added dropwise to a solution of 1-bromo-1-cyclopropylcyclopropane (1) (146.0 g, 907.0 mmol) in anhydrous Et2O (2.2 L) at −78 °C within 40 min. After stirring at −78 °C for an additional 25 min, an excess of dry ice was added in several portions (T ≤ −70 °C), and the mixture was allowed to slowly warm up to ambient temperature during a period of 2 h. The reaction was quenched with an ice-cold solution of KOH (60.0 g, 1.070 mol) in H2O (1 L), the aqueous layer was washed with ether (3 × 100 mL), and then acidified with conc. aq. HCl solution at 0–5 °C (ca. 175 mL). The resulting mixture was extracted with ether (4 × 300 mL), the combined organic phases were dried and concentrated under reduced pressure to give the acid 2 (73.2 g, 64%) as colorless crystals, mp 50–51 °C (lit. [17]: mp: 51–52 °C), which was used in the next step without further purification. Its NMR spectra were identical to the published ones [17].
Synthesis of tert-butyl 1-(cyclopropyl)cyclopropylcarbamate (3)
To a mechanically stirred solution of the acid 2 (70.60 g, ca. 560.0 mmol) in anhydrous acetone (1.7 L), was added Et3N (76.2 g, 105.0 mL, 753.0 mmol) dropwise at −5 °C. After additional stirring at this temperature for 15 min, neat ethyl chloroformate (103.7 g, 91.0 mL, 956.0 mmol) was added at the same temperature over a period of 30 min, and the resulting mixture was stirred at this temperature for an additional 2 h. Then a solution of NaN3 (75.0 g, 1.0 mol) in H2O (200 mL) was added over a period of 1.5 h. The reaction mixture was stirred at 0 °C for 1.5 h, concentrated under reduced pressure at 0 °C to about a half of the original volume, poured into ice-cold water (2 L), and the mixture extracted with diethyl ether (4 × 400 ml) and pentane (2 × 350 ml). The combined organic solutions were washed with ice-cold water (2 × 400 mL), dried under stirring with MgSO4 at 0 °C for 1 h and concentrated under reduced pressure at 0 °C/20–30 Torr. The residue was taken up with pentane (300 mL), dried and concentrated under the same conditions. It was then dissolved in anhydrous t-BuOH (200 mL), and this solution was added dropwise to anhydrous t-BuOH (1300 mL) kept at 80 °C under vigorous stirring over a period of 2.5 h. The resulting solution was heated under reflux for an additional 9 h. The main volume of t-BuOH (ca. 1300 mL) was distilled off under ambient pressure in a nitrogen flow. After cooling, the residue mixture was dried at 20 °C/0.1 Torr to give essentially pure carbamate 3 (84.0 g, 76%) as a colorless solid, mp 69–70 °C, Rf 0.38 (hexane/Et2O 5:1), which was used in the next step without further purification. 1H NMR (300 MHz, CDCl3) δ 4.91 (br s, 1H, NH), 1.39 (s, 9H, 3 CH3), 1.30–1.20 (br m, 1H, cPr-H), 0.64–0.57 (br m, 2H, cPr-H), 0.52–0.45 (br m, 2H, cPr-H), 0.37–0.31 (m, 2H, cPr-H), 0.09–0.04 (m, 2H, cPr-H); 13C NMR (62.9 MHz, CDCl3) δ 155.2 (C), 79.0 (C), 34.1 (C), 28.3 (3 CH3), 15.6 (CH), 11.9 (2 CH2), 2.6 (2 CH2); EIMS (70 eV) m/z: 141 (M+ − C4H8), 126, 96, 82, 58, 57, 43; HRMS–ESI (m/z): calcd for C11H19NNaO2, 220.1308; found, 220.1314.
Synthesis of (1-cyclopropyl)cyclopropylamine hydrochloride (4·HCl)
Under stirring, a solution of the carbamate 3 (84.0 g, 425.8 mmol) in Et2O (100 mL) was added to a ca. 5.0 N HCl solution in Et2O (700 mL) in one portion at 0 °C. The reaction mixture was stirred at 0 °C for 4 h and at ambient temperature for 20 h. The formed precipitate was filtered off, washed with Et2O (200 mL) and dried in a vacuum desiccator over P4O10 overnight to give 4·HCl (49.7 g, 87%) as a colorless powder, which slowly decomposes above ca. 135 °C and melts at 196–198 °C (dec.); 1H NMR (300 MHz, D2O) δ 1.30–1.26 (m, 1H, cPr-H), 0.71–0.60 and 0.60–0.55 (m AA'BB', 4H, cPr-H), 0.49–0.42 and 0.13–0.08 (m AA'BB', 4H, cPr-H).
When a solution of the intermediate azide in the preparation of 3 was not sufficiently dried, the thermolysis in t-BuOH along with tert-butylcarbamate 3 gave the 1,3-di(bicyclopropyl)urea (5) in up to 50% yield. Compound 5 was isolated as a colorless solid after deprotection of 3 with HCl/Et2O by evaporation of the mother liquor followed by recrystallization of the residue from hexane/CHCl3; mp 159–161 °C. The structure of 5 was confirmed by X-ray crystal structure analysis [26]. 5: 1H NMR (300 MHz, CDCl3) δ 5.21 (br s, 2H, NH), 1.28–1.16 (m, 2H, 2 CH cPr-H), 0.73–0.61 (m AA'BB', 8H, 4 CH2, cPr-H), 0.44–0.41 and 0.17–0.13 (m AA'BB', 8H, 4 CH2, cPr-H); 13C NMR (62.9 MHz, CDCl3) δ 158.8 (C), 33.9 (2 C), 15.5 (2 CH), 12.6 (2 CH2), 2.8 (6 CH2); EIMS (70 eV) m/z: 219 (M+ − H), 205 (M+ − H−CH2), 191 (M+ − H−C2H4), 124 (M+ − H−NC6H9), 96 (M+ − H−NC6H9−CO), 82 (M+ − H−NC6H9−CH2−CO).
Acknowledgments
This work was supported by the Land Niedersachsen.
This article is part 159 of the Series "Cyclopropyl Building Blocks for Organic Synthesis." For part 158 and 157 see [1] and [2], respectively.
Contributor Information
Sergei I Kozhushkov, Email: skozhus@gwdg.de.
Alexander F Khlebnikov, Email: alexander.khlebnikov@pobox.spbu.ru.
Rafael R Kostikov, Email: rakostikov@yandex.ru.
Dmitrii S Yufit, Email: d.s.yufit@durham.ac.uk.
Armin de Meijere, Email: ameijer1@uni-goettingen.de.
References
- 1.de Meijere A, Kozhushkov S I. Mendeleev Commun. 2010;20:301–311. doi: 10.1016/j.mencom.2010.11.001. [DOI] [Google Scholar]
- 2.Kozhushkov S I, Wagner-Gillen K, Khlebnikov A F, de Meijere A. Synthesis. 2010:3967–3973. doi: 10.1055/s-0030-1258964. [DOI] [Google Scholar]
- 3.Pracitto R, Kadow J F, Bender J A, Beno B R, Grant-Young K A, Han Y, Hewawasam P, Nickel A, Parcella K E, Yeung K-S, et al., inventors. Compounds for the treatment of hepatitis C. 2010/0063068 A1. U.S. Pat. Appl. 2010 Mar 11; Chem. Abstr.2010,152, 335190.
- 4.Pracitto R, Kadow J F, Bender J A, Beno B R, Grant-Young K A, Han Y, Hewawasam P, Nickel A, Parcella K E, Yeung K-S, et al., inventors. Compounds for the treatment of hepatitis C. 2010/0184800 A1. U.S. Pat. Appl. 2010 Jul 22; Chem. Abstr.2010,153, 204354.
- 5.Mita T, Furukawa Y, Iwasa M, Komoda M, inventors. Isoxazoline-substituted benzamide compound and pest control agent. 2008/108448 A1. WO Pat. Appl. 2008 Sep 12; Chem. Abstr.2008,149, 355887.
- 6.Chen C-L, Clark R B, Deng Y, He M, Plamondon L, Sun C, Xiao X-Y, inventors. Tetracycline compounds. 2010/129057 A2. WO Pat. Appl. 2010 Nov 11; Chem. Abstr.2010,153, 600600.
- 7.Vettiger T, Stoller A, Jackson D A, inventors. Process for the preparation of anthranilamide derivatives. 2008/031548 A1. WO Pat. Appl. 2008 Mar 20; Chem. Abstr.2008,148, 355784.
- 8.Vettiger T, Stoller A, Jackson D A, inventors. Process for the preparation of anthranilamide derivatives. 2008/031549 A1. WO Pat. Appl. 2008 Mar 20; Chem. Abstr.2008,148, 355782.
- 9.Loiseleur O, Hall R G, Stoller A D, Graig G W, Jeanguenat A, Edmunds A, inventors. Condensed anthranilamide derivatives as insecticides. 2009/024341 A2. WO Pat. Appl. 2009 Feb 26; Chem. Abstr.2009,150, 260188.
- 10.Hughes D J, Peace J E, Riley S, Russell S, Swanborough J J, Jeanguenat A, Renold P, Hall R G, Loiseleur O, Trah S, et al., inventors. Pesticidal mixtures containing bicyclic anthranilamides. 2007/009661 A2. WO Pat. Appl. 2007 Jan 25; Chem. Abstr.2007,146, 178834.
- 11.Loiseleur O, Durieux P, Trah S, Edmunds A, Jeanguenat A, Stoller A, Hughes D J, inventors. Pesticides containing a bicyclic bisamide structure. 2007/093402 A1. WO Pat. Appl. 2007 Aug 23; Chem. Abstr.2007,147, 301166.
- 12.Jeanguenat A, O'Sullivan A C, Mühlebach M, Trah S, Hall R G, inventors. Cyano anthranilamide insecticides. 2006/111341 A1. WO Pat. Appl. 2006 Oct 26; Chem. Abstr.2006,145, 455006.
- 13.O'Sullivan A C, Hughes D, Jeanguenat A, Mühlebach M, Loiseleur O, inventors. Heterocyclic diamide insecticidal agents. 2006/040113 A2. WO Pat. Appl. 2006 Apr 20; Chem. Abstr.2006,144, 364548.
- 14.Bertus P, Szymoniak J. Chem Commun. 2001:1792–1793. doi: 10.1039/B105293B. [DOI] [PubMed] [Google Scholar]
- 15.Bertus P, Szymoniak J. Synlett. 2007:1346–1356. doi: 10.1055/s-2007-980342. [DOI] [Google Scholar]
- 16.According to the SciFinder data bank, compound 4·HCl is commercially available from ChemBridge Corporation and other suppliers, however, at a price of 475 USD/g.
- 17.de Meijere A, Khlebnikov A F, Sünnemann H W, Frank D, Rauch K, Yufit D S. Eur J Org Chem. 2010:3295–3301. doi: 10.1002/ejoc.201000209. [DOI] [Google Scholar]
- 18.Kirmse W, Rode J, Rode K. Chem Ber. 1986;119:3672–3693. doi: 10.1002/cber.19861191214. [DOI] [Google Scholar]
- 19.Weinstock J. J Org Chem. 1961;26:3511. doi: 10.1021/jo01067a604. [DOI] [Google Scholar]
- 20.Jendralla H. Chem Ber. 1980;113:3585–3596. doi: 10.1002/cber.19801131116. [DOI] [Google Scholar]
- 21.de Meijere A, Kozhushkov S I, Späth T. Org Synth. 2002;78:142–151. Org. Synth.2004,Coll. Vol. 10, 88–97. [Google Scholar]
- 22.de Meijere A, Kozhushkov S I, Spaeth T, Zefirov N S. J Org Chem. 1993;58:502–505. doi: 10.1021/jo00054a040. [DOI] [Google Scholar]
- 23.Seebach D, Neumann H. Chem Ber. 1974;107:847–853. doi: 10.1002/cber.19741070311. [DOI] [Google Scholar]
- 24.Bailey W F, Patricia J J. J Organomet Chem. 1988;352:1–46. doi: 10.1016/0022-328X(88)83017-1. [DOI] [Google Scholar]
- 25.Brandl M, Kozhushkov S I, Yufit D S, Howard J A K, de Meijere A. Eur J Org Chem. 1998:2785–2795. doi: 10.1002/(SICI)1099-0690(199812)1998:12<2785::AID-EJOC2785>3.0.CO;2-R. [DOI] [Google Scholar]
- 26.CCDC-828827 (5) contains the supplementary crystallographic data for this paper. These data can be obtained free of charge via http://www.ccdc.cam.ac.uk/conts/retrieving.html (or from the Cambridge Crystallographic Data Centre, 12, Union Road, Cambridge CB21EZ, UK; fax: (+44)1223-336-033; or deposit@ccdc.cam.ac.uk).
- 27.Williams D B G, Lawton M. J Org Chem. 2010;75:8351–8354. doi: 10.1021/jo101589h. [DOI] [PubMed] [Google Scholar]


